SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. · 66-66 · CHINA
For SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP., import alert is 66-66; country is CHINA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Kanamycin; product code is 56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA, verified against its source on 2026-09-30.
- Firm
- SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CHINA verified
- Address
- 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA verified
- Date published
- 09/30/2009 verified
- Product code
- 56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Kanamycin verified
- FDA notes
- 10/10/2000 verified
What the source says
SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. Date Published : 09/30/2009 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Kanamycin Notes: 10/10/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html